Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACT: Tecarfarin vs Warfarin in Chronic Anticoagulation
NCT02522221Phase 3Unknown
- Sponsor
- Cadrenal Therapeutics
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tecarfarin in thromboembolism, thrombosis, sponsored by Cadrenal Therapeutics. Status: unknown.
02
Drugs
tecarfarin
03
Conditions
thromboembolismthrombosis
Beyond the preview
Go deeper on NCT02522221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522221.